| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |